TMO — Thermo Fisher Scientific Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Thermo Fisher Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,477	8,524	8,077	5,570	10,105
Net Total Accounts Receivable
Net Total Receivables	8,945	9,427	9,664	9,626	8,900
Total Inventory
Total Other Current Assets
Total Current Assets	20,113	25,229	24,589	22,137	28,707
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,864	10,873	11,004	10,795	10,565
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	95,123	97,154	98,726	97,321	110,343
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,436	17,010	14,012	13,332	15,189
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	54,330	53,176	51,991	47,737	56,928
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	40,793	43,978	46,735	49,584	53,415
Total Liabilities & Shareholders' Equity	95,123	97,154	98,726	97,321	110,343
Total Common Shares Outstanding